期刊文献+

他拉达非对肺动脉高压模型大鼠降钙素基因相关肽、p27及p-ERK1/2表达的影响 被引量:1

Expression of CGRP,p27 and p- ERK1 / 2 in Tadalafil- Intervened Pulmonary Arterial Remodeling Rats
下载PDF
导出
摘要 目的分析他拉达非对肺动脉高压模型大鼠降钙素基因相关肽(CGRP)、p27及p-ERK1/2表达的影响。方法将36只雄性SD大鼠随机分为肺动脉高压(PAH)组(A组),他拉达非组(B组)及对照组(C组),各12例。观察各组大鼠血流动力学及肺血管形态学变化,以Western Blot法分析肺动脉CGRP,p27及p-ERK1/2的表达。结果与A组比,B组聚天冬氨酸(PASP)、平均肺动脉压(m PAP)显著降低(P<0.05),游离右室壁(RV)/(左室+室间隔)(LV+S)在A,B组间无显著性差异(P>0.05),但均显著高于C组(P<0.05);A组右心室肥大程度及肺血管结构变化显著高于B组(P<0.05),且均显著高于C组(P<0.05);A组大鼠CGRP,p27表达显著降低(P<0.05),p-ERK1/2表达显著上调(P<0.05),经他拉达非干预后改善,但与C组相比,差异仍有统计学意义(P<0.05)。结论他拉达非能显著改善PAH模型大鼠的血管重构,CGRP及ERK1/2/p27在其中可能扮有重要作用。 Objective To analyze the expression of CGRP,p27 and p- ERK1 / 2 in Tadalafil- intervention pulmonary arterial remodeling rats. Methods 36 male SD rats were randomly divided into PAH model group( A),Tadalafil- intervention group( B) and control group( C), the blood flow dynamics and rats pulmonary vascular morphology change were observed, the expressions of pulmonary CGRP, p27 and p- ERK1 / 2 were analyzed. Results Compared with model group, the intervention group PASP, m PAP significantly reduced( P 〈0. 05), RV /( LV + S) had no significant difference( P 〉 0. 05), but both were higher than control group( P 〈 0. 05); the model rats right ventricular hypertrophy and pulmonary vascular structural changes was significantly higher than the intervention group( P 〈 0. 05);CGRP,p27 expression in model group was significantly reduced,p- ERK1 / 2 expression significantly increased( P 〈 0. 05),after Tadalafl intervention significantly improved,but also has a significant difference with control group( P 〈 0. 05). Conclusion Tadalafil significantly improve PAH model rat vascular remodeling,CGRP,ERK1 / 2 / p27 may play an important role.
作者 姜波
出处 《中国药业》 CAS 2015年第23期27-29,共3页 China Pharmaceuticals
关键词 他拉达非 肺动脉高压 降钙素基因相关肽 血管重构 tadalafil pulmonary hypertension CGRP ERK1 / 2
  • 相关文献

参考文献10

二级参考文献40

  • 1胡毅,冯奉仪,石远凯,周立强,顾大中,王奇璐.原发性中枢神经系统淋巴瘤28例临床分析[J].中华肿瘤杂志,2004,26(6):375-378. 被引量:22
  • 2李奋,周爱卿,蒋世良,李渝芬,韩玲,朱鲜阳,孔祥清,王广义,马沛然,张玉顺,华益民.动脉导管未闭封堵的临床研究[J].临床儿科杂志,2006,24(11):924-926. 被引量:37
  • 3刘丽波,杨智航,刘丽,付伟,薛一雪.缓激肽对脑胶质瘤大鼠紧密连接影响的形态学观察[J].解剖科学进展,2007,13(3):226-229. 被引量:13
  • 4Gerstner ER, Batchelor TI'. Primary central nervous system lym- phoma. Arch Neurol, 2010,67:291-297.
  • 5Rubenstein JL, Combs D, Rosenberg J, et al. Rituximab therapy for CNS lymphomas: targeting the leptomeningeal compartment. Blood, 2003, 101: 466-468.
  • 6Marcus R, Hagenbeek A. The therapeutic use of rituximab in non-Hodgkin's lymphoma. Eur J Haematol, 2007, 78:5-14.
  • 7Foran JM, Rohatiner AZ, Cunningham D, et al. Eur-opean phase II study of rituximab (chimeric anti-CD20 monoclonal antibody ) for patients with newly diagnosed mantle-cell lymphoma and previously treated mantle-cell lymphoma, immunocytoma, and small B-cell lymphocytic lymphoma. J Clin Oncol,2000,18:317.
  • 8Hu J, Ljubimova JY, Inoue S, et al. Phosphodiesterase type 5 inhibitors increase herceptin transport and treatment efficacy in mouse metastatic brain tumor model. PLoS One, 2010, 5 :e10108.
  • 9楼美清,卢亦成.血脑屏障和血瘤屏障.见:黄强,陈忠平,兰青主编.胶质瘤.第1版.北京:中国科学技术出版社,2000:84-92.
  • 10Lampson LA. Monoclonal antibodies in neuro-oncology: Getting past the blood brain barrier. MAbs, 2011,3:1-8.

共引文献17

同被引文献6

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部